iCBT for Children and Adolescents With Obsessive-compulsive Disorder II

July 6, 2022 updated by: PD Dr. Annette Conzelmann, University Hospital Tuebingen

Internet-based Cognitive Behavioral Psychotherapy for Children and Adolescents With Obsessive-compulsive Disorder II

Internet-based psychotherapy for children and adolescents with obsessive-compulsive symptoms and an age of 6 to 18 years. Sessions are verified with teleconferencing with an psychotherapist, children and their parents. The psychotherapy is supported by an App and a wristband to obtain psychophysiological data. The investigators have already successfully performed a feasibility study.The goal of the current proposal is to develop an internet and smart phone delivered CBT (iCBT) for the treatment of pediatric OCD on the bases of the feasibility study. Internal testing on iCBT therapy package and developmental workchanges has been done. The investigators are now evaluating effectiveness in an RCT.

Study Overview

Detailed Description

In this study the investigators test effectiveness of an internet-based therapy approach for children with obsessive-compulsive disorders in an RCT design with a waiting control group. The investigators are planninng the investigation of 20 patients in each group.Therapy is verified by experts via teleconferences and a therapy app. Outcomes for the treatment group are evaluated before randomization (baseline, t0), 16 weeks (end of treatment, t1), 32 weeks (follow-up 1, t2), and 48 weeks after randomization (follow-up 2, t3). For the waiting list-group, outcomes are measured before the first randomization (baseline), at 16 weeks (waiting list period), 32 weeks (end of treatment), 48 weeks after the first randomization (follow-up I) and 64 weeks after the first randomization (follow-up II).

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tuebingen, Germany
        • University Hospital Tuebingen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children and adolescents (ages 6-18) with a primary DSM-5 obsessive-compulsive disorder and at least 1 primary caretaker
  • German-speaking (child & caretakers)
  • Family home equipped with broadband connection and appropriate computer, monitor, HD webcam, and speaker and smart phone
  • written informed content of the child and his caretaker
  • OCD as highest treatment priority

Exclusion Criteria:

  • IQ below 70
  • not speaking and understanding German
  • A psychiatric comorbidity that makes participation clinically inappropriate (for example, primary anorexia nervosa), depression with suicidality, psychosis or any other psychiatric disorder that requires acute treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Internet-based psychotherapy
16 weeks of internet-based cognitive behavioral therapy
The goal is to develop an internet and smart phone delivered CBT (iCBT) for the treatment of pediatric OCD on the bases of our feasibility study. This group will start directly with therapy of 16 weeks. The waiting group gets the same intervention after 16 weeks of waiting.
ACTIVE_COMPARATOR: Internet-based psychotherapy waiting group
16 weeks of internet-based cognitive bahavioral therapy after waiting of 16 weeks
The goal is to develop an internet and smart phone delivered CBT (iCBT) for the treatment of pediatric OCD on the bases of our feasibility study. This group will start directly with therapy of 16 weeks. The waiting group gets the same intervention after 16 weeks of waiting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Schedule for Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime Version (K-SADS-PL)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Clinical interview for psychiatric disorders for children and parents.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Interview/questionnaire for obsessive-compusive disorders.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Children's Global Assessment Scale (CGAS)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The CGAS is a measure of level of functioning in children and adolescents.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Child Behavior Checklist (CBCL/6-18R)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 113-item 3-point questionnaire for parents that assesses a wide range of child behavioral and emotional problems.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents (KINDL)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 24 item 5 point scale self-report questionnaire for children and parents to quality of life.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Child Obsessive Compulsive Disorder Impact Scale (COIS-RC)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 33-item self-report questionnaire to the impact of OCD symptoms on the psychosocial functioning of the children.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Youth Self-Report (YSR/11-18R)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A 112 item 3-point scale completed by the children themselves and addresses a variety of behavioral and emotional problems.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Depression Inventory for Children and Adolescents (DIKJ)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The questionnaire measures depressive symptoms in the children. It has 26 items and a 4 point scale.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Junior temperament and character inventory (JTCI)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The questionnaire assesses temperament characteristics with 103/86 items and a 5-point scale.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Screen for Child Anxiety Related Emotional Disorders (SCARED)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
The SCARED assesses DSM-IV anxiety symptoms.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Clinical Global Impressions-Severity (CGI-S)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A clinical 7-point rating scale of symptom severity.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Clinical Global Impressions-Improvement (CGI-I)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
A clinical 7-point rating scale of symptom severity.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Impairment by OCD symptoms
Time Frame: Every day throughout the therapy process
Children and parents indicate impairment by OCD via app.
Every day throughout the therapy process
Change in Extend of avoidance behavior
Time Frame: Every day throughout the therapy process
Children and parents indicate extend of avoidance behavior via app.
Every day throughout the therapy process
Change in Daily mood
Time Frame: Every day throughout the therapy process
Children indicate their mood via app.
Every day throughout the therapy process
Change in How the day has been
Time Frame: Every day throughout the therapy process
Children indicate how good the day has been via app.
Every day throughout the therapy process
Change in How strong OCD is
Time Frame: Every day throughout the therapy process
Children and parants indicate how strong OCD is via app.
Every day throughout the therapy process
Change in How the week has been
Time Frame: weekly throughout the therapy process
Children and parants indicate how the week has been via app.
weekly throughout the therapy process
Change in Anxiety ratings during exposures
Time Frame: Every exposure throughout the therapy process
Children indicate how high anxiety was during exposures via app.
Every exposure throughout the therapy process
Change in Heart rate variability
Time Frame: Every day throughout the therapy process
Heart rate variability as an indicator of stress levels is assessed with wristbands.
Every day throughout the therapy process
Change in time the OCD takes
Time Frame: Every day throughout the therapy process
Children and parants indicate how much time OCD takes via app.
Every day throughout the therapy process
Change in HEXACO- Personality Inventory-Revised (HEXACO-PI-R)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
This questionnaire assesses the core personality traits of children.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in Engagement- Fragebogen
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Questionnaire for emotional, cognitive and behavioral engagement at school with 5 items each.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Change in How convinced the patient of his/her OCD thoughts is
Time Frame: every exposure
assessed by App
every exposure
Change in Ulmer Life Quality Inventory for parents of chronically ill children(ULQIE)
Time Frame: baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks
Questionnaire to life quality of parents related to the impairment through the illness of the child.
baseline,16 weeks, 32 weeks, 48 weeks, 64 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trauma History Questionaire (THQ)
Time Frame: baseline
This is a 5-point scale and 28 items that measures trauma experience such as sexual abuse or emotional neglect.
baseline
Essener Trauma Inventory for Children and Adolescents (ETI-KJ)
Time Frame: baseline
This questionnaire measures posttraumatic symptoms.
baseline
Childhood trauma questionaire (CTQ)
Time Frame: baseline
This is a 24-item measure to traumatic events.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 4, 2019

Primary Completion (ACTUAL)

April 30, 2022

Study Completion (ACTUAL)

April 30, 2022

Study Registration Dates

First Submitted

July 31, 2021

First Submitted That Met QC Criteria

August 31, 2021

First Posted (ACTUAL)

September 8, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 8, 2022

Last Update Submitted That Met QC Criteria

July 6, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We share study matterial and statistical outputs.

IPD Sharing Time Frame

Any time before and after completion of the study for 10 years.

IPD Sharing Access Criteria

Upon request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychotherapy Intervention Evaluation

Clinical Trials on Cognitive-behavioral psychotherapy

Subscribe